NCT05843617 is a NA clinical trial of Liposomal Vitamin C in Bioavailability of Vitamin C, sponsored by AronPharma Sp. z o. o..

Who is sponsoring NCT05843617?

NCT05843617 is sponsored by AronPharma Sp. z o. o..

What drugs are being tested in NCT05843617?

Interventions in NCT05843617: Liposomal Vitamin C, Traditional Vitamin C.

What condition does NCT05843617 study?

NCT05843617 studies Bioavailability of Vitamin C.

Is NCT05843617 still recruiting?

NCT05843617 is currently completed. Last updated 1 August 2024.

Last reviewed 2024-08-01 · How we verify

NCT05843617

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Bioavailability of Liposomal and Traditional Formulation of Vitamin C

Completed NA Last updated 1 August 2024

What this trial tests

NA trial testing Liposomal Vitamin C in Bioavailability of Vitamin C in 10 participants. Completed in 9 June 2022.

Timeline

28 February 2022

Primary endpoint
9 June 2022

9 June 2022

Quick facts

Lead sponsor	AronPharma Sp. z o. o.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	other
Enrollment	10
Start date	28 February 2022
Primary completion	9 June 2022
Estimated completion	9 June 2022
Sites	1 location across Poland

Drugs / interventions tested

Liposomal Vitamin C
Traditional Vitamin C

Conditions studied

Bioavailability of Vitamin C — all drugs for Bioavailability of Vitamin C →

Sponsor

AronPharma Sp. z o. o.

Who can join

Adults 18 to 65, any sex, with Bioavailability of Vitamin C. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study was to compare the profiles of vitamin C serum concentration in healthy volunteers after the single oral administration either in a liposomal or traditional formulation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other AronPharma Sp. z o. o. trials

Trials by the same sponsor.

NCT06017661 — Investigation of a Polyphenol-rich Preparation as Support for Oncology Patients Undergoing Gastrointestinal Tumor Resect · NA · unknown
NCT05994638 — Polyphenol Rich Aerosol as a Support for Cancer Patients in Minimizing Side Effects After a Radiation Therapy · NA · unknown
NCT06004570 — Effects of a Combination of Polyphenol-rich Extracts on the Protection of Retinal Cells Against Blue Light in the Preven · NA · completed
NCT05994586 — The Efficacy of AP029 Mix in Patients With Impaired Carbohydrate Metabolism · NA · unknown
NCT05990764 — Effects of a Combination of Polyphenol-rich Extracts, Prebiotics, and Hydrolyzed Fiber on the Quality of Life of Patient · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05843617 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by AronPharma Sp. z o. o.
Last refreshed: 1 August 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05843617.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing